Scholar Rock Ownership | Who Owns Scholar Rock?
Scholar Rock Ownership Summary
Scholar Rock is owned by 59.59% institutional investors, 3.94% insiders, and 36.47% retail investors. Fmr is the largest institutional shareholder, holding 12.43% of SRRK shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.77% of its assets in Scholar Rock shares.
SRRK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Scholar Rock | 59.59% | 3.94% | 36.47% |
| Sector | Healthcare Stocks | 232.86% | 10.65% | -143.51% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 14.01M | 12.43% | $521.81M |
| Artal group | 11.26M | 11.74% | $93.79M |
| Siren | 9.25M | 8.21% | $344.47M |
| Blackrock funding, inc. /de | 7.22M | 6.35% | $317.91M |
| Price t rowe associates inc /md/ | 6.88M | 6.11% | $256.33M |
| Blackrock | 5.66M | 5.91% | $47.18M |
| Samsara biocapital | 5.61M | 4.98% | $209.02M |
| Vanguard group | 5.20M | 4.57% | $228.86M |
| Wellington management group llp | 4.55M | 4.03% | $169.29M |
| Redmile group | 3.90M | 3.46% | $145.40M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Samsara biocapital | 5.61M | 27.29% | $209.02M |
| Redmile group | 3.90M | 14.15% | $145.40M |
| Siren | 9.25M | 13.48% | $344.47M |
| Fairmount funds management | 1.82M | 6.11% | $67.93M |
| Stempoint capital lp | 726.20K | 5.42% | $27.04M |
| Eagle health investments lp | 363.30K | 3.52% | $16.00M |
| Nationale-nederlanden powszechne towarzystwo emerytalne | 769.44K | 3.01% | $33.89M |
| Vestal point capital, lp | 1.50M | 2.52% | $55.86M |
| Bellevue group | 3.24M | 2.51% | $120.83M |
| Artal group | 11.26M | 2.39% | $93.79M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 4.55M | 0.03% | 2.52M |
| Holocene advisors, lp | 2.46M | 0.21% | 2.46M |
| Norges bank | 2.08M | 0.01% | 2.08M |
| Jennison associates | 2.80M | 0.07% | 1.19M |
| Balyasny asset management | 933.43K | 0.05% | 933.43K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 6.88M | 0.03% | -1.88M |
| Commodore capital lp | - | - | -1.45M |
| Polar capital | 794.08K | 0.14% | -705.92K |
| Marshall wace, llp | 973.91K | 0.04% | -666.52K |
| Man group | 34.18K | 0.00% | -566.97K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Holocene advisors, lp | 2.46M | 0.21% | 2.46M | $91.67M |
| Norges bank | 2.08M | 0.01% | 2.08M | $91.60M |
| Balyasny asset management | 933.43K | 0.05% | 933.43K | $33.06M |
| Orbis allan gray | 302.25K | 0.05% | 302.25K | $11.26M |
| Logos global management lp | 175.00K | 0.58% | 175.00K | $6.52M |
Sold Out
| Holder | Change |
|---|---|
| Hughes financial services | -1.00 |
| Td private client wealth | -9.00 |
| Principal securities | -9.00 |
| Montag a & associates | -10.00 |
| Nelson, van denburg & campbell wealth management group | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 212 | -21.48% | 67,775,501 | -41.57% | 59 | 0.56% | 120 | -18.37% | 56 | -11.11% |
| Sep 30, 2025 | 265 | 7.29% | 114,678,020 | 4.47% | 101 | 1.07% | 143 | 7.52% | 63 | -8.70% |
| Jun 30, 2025 | 244 | 2.09% | 109,732,730 | 6.85% | 97 | 1.15% | 131 | 6.50% | 68 | -1.45% |
| Mar 31, 2025 | 240 | -5.88% | 104,870,614 | 0.44% | 93 | 0.81% | 124 | -21.52% | 70 | 16.67% |
| Dec 31, 2024 | 71 | -58.72% | 10,857,075 | -87.43% | 11 | 0.14% | 47 | -44.05% | 15 | -71.70% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 5.48M | 4.77% | 19.90K |
| Fidelity Growth Compy Commingled Pl O | 3.59M | 4.49% | 36.80K |
| Fidelity Growth Company Fund | 3.89M | 3.39% | 15.00K |
| BB Biotech AG Ord | 3.24M | 3.17% | 305.67K |
| Vanguard Health Care Inv | 2.75M | 2.70% | 1.10M |
| Vanguard Total Stock Mkt Idx Inv | 2.79M | 2.43% | 16.94K |
| Vanguard US Total Market Shares ETF | 2.29M | 2.42% | - |
| iShares Russell 2000 ETF | 2.11M | 1.84% | -17.25K |
| State Street® SPDR® S&P® Biotech ETF | 1.96M | 1.71% | 29.54K |
| T. Rowe Price New Horizons | 1.86M | 1.62% | 12.37K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 16, 2026 | Woods Keith | Chief Operating Officer | Sell | $506.65K |
| Apr 16, 2026 | Vaishnaw Akshay | President of R&D | Sell | $607.09K |
| Apr 16, 2026 | Sinha Vikas | Chief Financial Officer | Sell | $516.07K |
| Apr 16, 2026 | Hallal David | Chief Executive Officer | Sell | $1.52M |
| Feb 23, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Sell | $9.70K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 4 |
| 2026 Q1 | - | 18 |
| 2025 Q4 | 9 | 3 |
| 2025 Q3 | - | 7 |
| 2025 Q2 | - | 22 |
SRRK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools